Protective Effect of _L-Theanine on Haloperidol- Induced Orofacial

10.4077/CJP.2018.BAG529

Cheng-Neng Chen；Kuo-Chi Chang；Mao-Hsien Wang；Hsiang-Chien Tseng；Hung-Sheng Soung

haloperidol ； _L-Theanine ； orofacial dyskinesia ； striatum

The Chinese Journal of Physiology

61卷1期（2018 / 02 / 28）

35 - 41

英文

Tardive dyskinesia (TD) is a severe side effect of chronic neuroleptic treatment consisting of abnormal involuntary movements, characterized by orofacial dyskinesia (OD). Haloperidol (HAL)- induced OD has been widely used as an animal model to study the neuropathophysiology of human TD with its pathophysiology strongly associated with striatal oxidative stress. _L-Theanine (LT), one of the major amino acid components in green tea, has potent antioxidative effects and is able to protect against various oxidative injuries. In this study, we examined the potential protective effects of LT on HAL-induced behavioral and neurochemical dysfunction in rats. HAL treatment (1 mg/kg i.p. for 21 days) induced significant increases (P ＜ 0.001) in the frequency of vacuous chewing movement (VCM) and tongue protrusion (TP) as well as the duration of facial twitching (FT). LT treatment (100, 300 mg/kg orally for 35 days, starting 14 days before HAL injection) was able to prevent most of the HAL-induced OD. LT treatment was also able to reduce the lipid peroxidation (LPO) production, and enhance the antioxidation power in striatum from rats with HAL treatment. The above results indicate that LT has a protective role against HAL-induced OD, probably via its powerful antioxidative properties. Thus, LT may have a clinically relevant therapeutic effect in delaying or treating TD.

1. Beers, R.F.Jr.,Sizer, I.W.(1952).A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.J. Biol. Chem.,195,133-140.
2. Bishnoi, M.,Chopra, K.,Kulkarni, S.K.(2007).Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.Pharmacol. Rep.,59,181-191.
3. Budantsev, AIu.,Kisliuk, O.S.,Shul'govskiĭ, V.V.,Rykunov, D.S.,Iarkov, A.V.(1993).The brain in stereotaxic coordinates.Zh Vyssh Nerv Deiat Im I P Pavlova.,43,1045-1051.
4. Burger, M.E.,Fachinetto, R.,Zeni, G.,Rocha, J.B.(2005).Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.Pharmacol. Biochem. Behav.,81,608-615.
5. Cho, C.H.,Lee, H.J.(2013).Oxidative stress and tardive dyskinesia: pharmacogenetic evidence.Prog. Neuropsychopharmacol. Biol. Psychiatry,46,207-213.
6. Datta, S.,Jamwal, S.,Deshmukh, R.,Kumar, P.(2016).Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.Eur. J. Pharmacol.,771,229-235.
7. Dutra, R.C.,Andreazza, A.P.,Andreatini, R.,Tufik, S.,Vital, M.A.(2002).Behavioral effects of MK-801 on reserpine-treated mice.Prog. Neuropsychopharmacol. Biol. Psychiatry,26,487-495.
8. Ellman, G.L.(1959).Tissue sulfhydryl groups.Arch. Biochem. Biophys.,82,70-77.
9. Glazer, W.M.,Morgenstern, H.,Schooler, N.,Berkman, C.S.,Moore, D.C.(1990).Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.Brit. J. Psychiatry,157,585-592.
10. Hashimoto, M.,Tanabe, Y.,Fujii, Y.,Kikuta, T.,Shibata, H.,Shido, O.(2005).Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats.J. Nutr.,135,549-555.
11. Kakuda, T.(2011).Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction.Pharmacol. Res.,64,162-168.
12. Kamyar, M.,Razavi, B.M.,Hasani, F.V.,Mehri, S.,Foroutanfar, A.,Hosseinzadeh, H.(2016).Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism.Iran J. Basic Med. Sci.,19,1070-1079.
13. Kane, J.M.,Smith, J.M.(1982).Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.Arch. Gen. Psychiatry,39,473-481.
14. Lohr, J.B.,Kuczenski, R.,Niculescu, A.B.(2003).Oxidative mechanisms and tardive dyskinesia.CNS Drugs,17,47-62.
15. Macêdo, D.S.,Oliveira, G.V.,Gomes, P.X.,Araújo, F.Y.,Souza, C.M.,Vasconcelos, S.M.,Viana, G.S.,Sousa, F.C.,Carvalho, A.F.(2011).B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.Behav. Pharmacol.,22,674-680.
16. Misra, H.P.,Fridovich, I.(1972).The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.J. Biol. Chem.,247,3170-3175.
17. Nade, V.S.,Kawale, L.A.,Yadav, A.V.(2010).Protective effect of Morus alba leaves on haloperidol-induced orofacial dyskinesia and oxidative stress.Pharm. Biol.,48,17-22.
18. Ohkawa, H.,Ohishi, N.,Yagi, K.(1979).Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.Anal. Biochem.,95,351-358.
19. Paris, I.,Martinez-Alvarado, P.,Cárdenas, S.,Perez-Pastene, C.,Graumann, R.,Fuentes, P.,Olea-Azar, C.,Caviedes, P.,Segura-Aguilar, J.(2005).Dopamine-dependent iron toxicity in cells derived from rat hypothalamus.Chem. Res. Toxicol.,18,415-419.
20. Patil, R.,Hiray, Y.,Shinde, S.,Langade, P.(2012).Reversal of haloperidol-induced orofacial dyskinesia by Murraya koenigii leaves in experimental animals.Pharm. Biol.,50,691-697.
21. Pérez-Vargas, J.E.,Zarco, N.,Vergara, P.,Shibayama, M.,Segovia, J.,Tsutsumi, V.,Muriel, P.(2016).L-Theanine prevents carbon tetrachloride-induced liver fibrosis via inhibition of nuclear factor κB and down-regulation of transforming growth factor β and connective tissue growth factor.Hum. Exp. Toxicol.,35,135-146.
22. Raudenska, M.,Gumulec, J.,Babula, P.,Stracina, T.,Sztalmachova, M.,Polanska, H.,Adam, V.,Kizek, R.,Novakova, M.,Masarik, M.(2013).Haloperidol cytotoxicity and its relation to oxidative stress.Mini Rev. Med. Chem.,13,1993-1998.
23. Sumathi, T.,Shobana, C.,Thangarajeswari, M.,Usha, R.(2015).Protective effect of L-Theanine against aluminium induced neurotoxicity in cerebral cortex, hippocampus and cerebellum of rat brain - histopathological, and biochemical approach.Drug Chem. Toxicol.,38,22-31.
24. Terashima, T.,Takido, J.,Yokogoshi, H.(1999).Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine.Biosci. Biotechnol. Biochem.,63,615-618.
25. Thakur, K.S.,Prakash, A.,Bisht, R.,Bansal, P.K.(2015).Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.J. Renin Angiotensin Aldosterone Syst.,16,917-929.
26. Thangarajan, S.,Deivasigamani, A.,Natarajan, S.S.,Krishnan, P.,Mohanan, S.K.(2014).Neuroprotective activity of L-Theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.Int. J. Neurosci.,124,673-684.
27. Yin, C.,Gou, L.,Liu, Y.,Yin, X.,Zhang, L.,Jia, G.,Zhuang, X.(2011).Antidepressant-like effects of L-Theanine in the forced swim and tail suspension tests in mice.Phytother. Res.,25,1636-1639.
28. Yokogoshi, H.,Kato, Y.,Sagesaka, Y.M.,Takihara-Matsuura, T.,Kakuda, T.,Takeuchi, N.(1995).Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats.Biosci. Biotechnol. Biochem.,59,615-618.
29. Zhang, G.,Miura, Y.,Yagasaki, K.(2002).Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats.Biosci. Biotechnol. Biochem.,66,711-716.
30. Zheng, G.,Sayama, K.,Okubo, T.,Juneja, L.R.,Oguni, I.(2004).Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice.In Vivo,18,55-62.
31. Zukhurova, M.,Prosvirnina, M.,Daineko, A.,Simanenkova, A.,Petrishchev, N.,Sonin, D.,Galagudza, M.,Shamtsyan, M.,Juneja, L.R.,Vlasov, T.(2013).L-Theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated injury in the rat model of cerebral ischemia-reperfusion.Phytother. Res.,27,1282-1287.

1. Mao-Hsien Wang,Kuo-Chi Chang,Hung-Sheng Soung,Hsiang-Chien Tseng,Chih-Chuan Yang,Cheng-Chia Tsai(2019).Possible Nitric Oxide Mechanism Involved in the Protective Effect of L-theanine on Haloperidol-Induced Orofacial Dyskinesia.The Chinese Journal of Physiology,62(1),17-26.